CoChat

Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis

Open access
Xie, Wenting, Su, Fugui, Wang, Guizhong, Peng, Zichong, Xu, Yaomin, Zhang, Yi, Xu, Ningning, Hou, Kaijian, Hu, Zhuping, Chen, Yan, Chen, Rongping · 2022 · Frontiers in Pharmacology
Cited by 91

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background: Insulin secretory agents are commonly used to treat type 2 diabetes. However, traditional insulin secretory agents such as sulfonylureas and glinides have side effects of hypoglycemia. In recent years, researchers have discovered that berberine can inhibit the voltage-gated k+ channels of pancreatic β cell membrane and promote insulin secretion without causing hypoglycemia, because the glucose-lowering effects of berberine are only under hyperglycemic conditions or in a high-glucose-dependent manner. In order to shed light on the glucose-lowing effects of berberine in type 2 diabetes with different baseline fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c), we conducted a meta-analysis of randomized controlled trials. Methods: We searched eight databases, which included PubMed, EMBASE, Web of Science, the Cochrane Library, and the Chinese databases such as Sino-Med, China National Knowledge Infrastructure (CNKI), Wanfang Database, and VIP Database for Chinese Technical Periodicals, for randomized controlled trials, with berberine as the intervention and patients with type 2 diabetes mellitus as subjects, published up until November 2021. We analyzed the glucose-lowing effects of berberine, including its effects on FPG, HbA1c and 2-h plasma blood glucose (2hPBG), by calculating weighted mean differences (WMD) and 95% confidence interval (CI). To assess the safety of berberine, we analyzed the incidence of total adverse events and hypoglycemia by calculating relative risk (RR) and 95% CI. Results: Thirty-seven studies involving 3,048 patients were included in the meta-analysis. The results showed that berberine could reduce FPG (WMD = -0.82 mmol/L, 95% CI (-0.95, -0.70)), HbA1c (WMD = -0.63%, 95% CI (-0.72, -0.53)), and 2hPBG (WMD = -1.16 mmol/L, 95% CI (-1.36, -0.96)), with all results being statistically significant. Subgroup analyses revealed that the glucose-lowering effect of berberine was associated with baseline mean FPG and HbA1c in type 2 diabetes. In addition, berberine alone or in combination with oral hypoglycemic agents (OHAs) in the treatment of T2DM did not significantly increase the incidence of total adverse events (RR = 0.73, 95% CI (0.55, 0.97), p = 0.03) and the risk of hypoglycemia (RR = 0.48, 95% CI (0.21, 1.08), p = 0.08). Conclusion: Berberine has a glucose-lowering effect, which is related to the baseline FPG and HbA1c levels of patients. Treatment with berberine may be safe since it does not increase the incidence of total adverse events and the risk of hypoglycemia. Systematic Review Registration:https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=292975, identifier CRD42021292975.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2022.1015045

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 66

  1. Budnitz, 2011, Emergency hospitalizations for adverse drug events in older Americans, N. Engl. J. Med., 365, 2002, 10.1056/NEJMsa1103053 · DOI · Paper page
  2. Cao, 2007, Clinical Research on Multiple factor intervention of improving the insulin resistance
  3. Chang, 2015, Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies, Biochem. Cell Biol., 93, 479, 10.1139/bcb-2014-0107 · DOI · Paper page
  4. Chang, 2020, Therapeutic effects of bcg vaccination on type 1 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials, J. Diabetes Res., 2020, 8954125, 10.1155/2020/8954125 · DOI
  5. Di Pierro, 2012, Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control, Diabetes Metab. Syndr. Obes., 5, 213, 10.2147/dmso.S33718 · DOI · Paper page
  6. Dong, 2017, Effect of berberine combined with metformin on serum inflammatory factors and islet function in type 2 diabetes mellitus, J. Clin. pathology, 37, 1418
  7. Fan, 2018, Effectiveness evaluation analysis on berberine tablets combination with metformin treating type 2 diabetes, Mod. Hosp., 18, 731, 10.3969/j.issn.1671-332X.2018.05.033 · doi:10.3969/j.issn.1671-332x.2018.05.033
  8. Finol-Urdaneta, 2012, Block of Kv1.7 potassium currents increases glucose-stimulated insulin secretion, EMBO Mol. Med., 4, 424, 10.1002/emmm.201200218 · DOI
  9. Gu, 2010, Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics, Talanta, 81, 766, 10.1016/j.talanta.2010.01.015 · DOI · Paper page
  10. Guo, 2018, Effect and mechanism of baicalein on insulin secretion in rats, Chin. Pharmacol. Bull., 34, 820, 10.3969/j.issn.1001-1978.2018.06.016 · doi:10.3969/j.issn.1001-1978.2018.06.016
  11. Guo, 2021, The effect of berberine on metabolic profiles in type 2 diabetic patients: A systematic review and meta-analysis of randomized controlled trials, Oxid. Med. Cell. Longev., 2021, 2074610, 10.1155/2021/2074610 · DOI · Paper page
  12. Jacobson, 2020, Ion channels of the islets in type 2 diabetes, J. Mol. Biol., 432, 1326, 10.1016/j.jmb.2019.08.014 · DOI
  13. Jiang, 2019, Effect of berberine hydrochloride tablets combined with metformin on blood glucose control and quality of life in patients with type 2 diabetes mellitus, Chronic Pathematology J., 8, 1228, 10.16440/j.cnki.1674-8166.20190912.004 · doi:10.16440/j.cnki.1674-8166.20190912.004
  14. Kakei, 2016, Glucose and GTP-binding protein-coupled receptor cooperatively regulate transient receptor potential-channels to stimulate insulin secretion [Review], Endocr. J., 63, 867, 10.1507/endocrj.EJ16-0262 · DOI
  15. Klein-Schwartz, 2016, Treatment of sulfonylurea and insulin overdose, Br. J. Clin. Pharmacol., 81, 496, 10.1111/bcp.12822 · DOI · Paper page
  16. Lang, 2016, Efficacy and safety of berberine in the treatment of type 2 diabetes mellitus, Health Guide, 35, 212
  17. Li, 2008, Advances in the study of berberine and its derivatives, Acta Pharm. Sin., 43, 773
  18. Li, 2021, Research progress of berberine in the treatment of diabetes and its complications, J. Hubei Univ. Sci. Technol. Sci., 35, 448, 10.16751/j.cnki.2095-4646.2021.05.0448 · doi:10.16751/j.cnki.2095-4646.2021.05.0448
  19. Li, 2008, Clinical observation of berberine combined with metformin in the treatment of type 2 diabetes mellitus, Hubei J. Traditional Chin. Med., 30, 34
  20. Li, 2014, Clinical efficacy and safety of berberine in the treatment of type 2 diabetes mellitus, 226
  21. Li, 2016, The clinical effect of sulfonylurea metformin and berberine in the treatment of diabetes, China Contin. Med. Educ., 8, 174
  22. Li, 2007, Effect of berberine combined with glipizide on type 2 diabetes, J. Clin. Res., 24
  23. Liang, 2019, Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: A systematic literature review and a meta-analysis, Endocr. J., 66, 51, 10.1507/endocrj.EJ18-0109 · DOI
  24. Liao, 2020, Action mechanism of berberine on diabetes mellitus and its complications, Med. Recapitulate, 26, 2637
  25. Ligtenberg, 1997, Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man, Eur. J. Clin. Invest., 27, 685, 10.1046/j.1365-2362.1997.1710716.x · doi:10.1046/j.1365-2362.1997.1710716.x
  26. Liu, 2008, Effect of berberine on islet p-cell function in type 2 diabetes mellitus(damp-heat type), Chin. J. Inf. TCM, 15, 12
  27. Liu, 2004, Effect of berberine in adjuvant treatment of type II diabetes mellitus, J. Sichuan Traditional Chin. Med., 22, 46
  28. Liu, 2013, Effect of metformin combined with berberine in the treatment of incipient type 2 diabetes mellitus, zhejiang J. Integr. traditional Chin. West. Med., 23, 380
  29. Lv, 2020, Mechanisms and characteristics of sulfonylureas and glinides, Curr. Top. Med. Chem., 20, 37, 10.2174/1568026620666191224141617 · DOI
  30. Nagy, 2018, Glycogen phosphorylase inhibition improves beta cell function, Br. J. Pharmacol., 175, 301, 10.1111/bph.13819 · DOI
  31. Pratley, 2001, The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus, Diabetologia, 44, 929, 10.1007/s001250100580 · DOI · Paper page
  32. Riefflin, 2015, The effect of glibenclamide on insulin secretion at normal glucose concentrations, Diabetologia, 58, 43, 10.1007/s00125-014-3399-1 · DOI
  33. Rolland, 2002, G protein-independent activation of an inward Na(+) current by muscarinic receptors in mouse pancreatic beta-cells, J. Biol. Chem., 277, 38373, 10.1074/jbc.M203888200 · DOI · Paper page
  34. Sheng, 2009, The level of serum inflammatory factors in patients with T2DM and the impact of intervention after Berberine treatment
  35. Sun, Regulation of ion channels on insulin secretion in islet β cells, Life Sci. Res., 26, 59, 10.16605/j.cnki.1007-7847.2020.11.0262 · doi:10.16605/j.cnki.1007-7847.2020.11.0262
  36. Sun, 2017, Effect of Berberine on the serum levels of IL-10, IL-6 and CRP in patients with type 2 diabetes mellitus, J. Changchun Univ. Chin. Med., 33, 431
  37. Tokajuk, 2015, Antidiabetic drugs and risk of cancer, Pharmacol. Rep., 67, 1240, 10.1016/j.pharep.2015.05.005 · DOI
  38. Tong, 2019, Study on hypoglycemic and hypotensive effects and mechanisms of total glycosides of Plantaginis semen
  39. Wang, 2008, Effect of berberine on blood glucose, blood lipid and serum leptin of primary type 2 diabetes mellitus patients
  40. Wei, 2021, Effect of berberine combined with metformin and acarbose in the treatment of newly diagnosed type 2 diabetes mellitus, Contemp. Med. Symp., 19, 139, 10.3969/j.issn.2095-7629.2021.11.084 · doi:10.3969/j.issn.2095-7629.2021.11.084
  41. Wu, 2019, Compound traditional Chinese medicine in treatment of diabetes, J. Chin. Materia Medica, 44, 1104, 10.19540/j.cnki.cjcmm.20181212.001 · DOI
  42. Wu, 2020, Effect of berberine on atherosclerosis and gut microbiota modulation and their correlation in high-fat diet-fed ApoE-/- mice, Front. Pharmacol., 11, 223, 10.3389/fphar.2020.00223 · DOI · Paper page
  43. Xiang, 2011, A study of two anti-inflammatory drugs in patients with incipient type 2 diabetes, J. Pract. DIABETOLOGY, 7, 51
  44. Xing, 2017, Progress in pharmacological effects and clinical applications of berberine, Chin. J. Pharmacol. Toxicol., 31, 491, 10.3867/j.issn.1000-3002.2017.06.001 · doi:10.3867/j.issn.1000-3002.2017.06.001
  45. Xu, 2008, Effects of berberine and piogntazone oil type 2 diabetes acute insulin secretion and adiponecttn, Hainan Med., 19
  46. Xue, 2012, Efficacy of sulfonylureas combined with berberine metformin in the treatment of diabetes, Shaanxi J. Tradit. Chin. Med., 33, 1335
  47. Yang, 2008, Effect on different model intervention of improving the 2 diabetes insulin resistance
  48. Yang, 2010, Clinical observation of berberine hydrochloride combined with acarbose in the treatment of type 2 diabetes, Chin. J. Prim. Med. Pharm., 24, 3422
  49. Yang, 2014, Ionic mechanisms in pancreatic β cell signaling, Cell. Mol. Life Sci., 71, 4149, 10.1007/s00018-014-1680-6 · DOI
  50. Yang, 2020, Clinical study of berberine hydrochloride tablets combined with metformin in the treatment of incipient type 2 diabetes mellitus, Shanghai J. Traditional Chin. Med., 54
  51. Yao, 2015, Clinical observation of triple therapy in the treatment of type 2 diabetes mellitus, China Pharm., 29, 4107, 10.6039/j.issn.1001-0408.2015.29.26 · doi:10.6039/j.issn.1001-0408.2015.29.26
  52. Yao, 2013, Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models, J. Ethnopharmacol., 150, 285, 10.1016/j.jep.2013.08.043 · DOI
  53. Ye, 2021, Analysis of the value of sulfonylureas and berberine metformin in the treatment of diabetes, Living Sci., 24, 263, 10.3969/j.issn.1672-9714.2021.18.263 · doi:10.3969/j.issn.1672-9714.2021.18.263
  54. Ye, 2010, Clinical efficacy of berberine treatment of diabetes, Mod. Hosp., 10, 9
  55. Yin, 2011, Effects of berberine hydrochloride on blood glucose, insulin and blood lipid in newly diagnosed type 2 diabetes mellitus, Acta Acad. Med. Xuzhou, 31, 40
  56. You, 2007, Clinical observation on the effect of berberine on urinary type IV collagen in diabetic patients, Chin. Hosp. Pharm. J., 6, 793
  57. Yu, 2020, Study on the effect of berberine hydrochloride combined with metformin on hypoglycemic effect and islet function in patients with T2DM
  58. Zhang, 2017, Analysis of the value of sulfonylureas and berberine metformin in the treatment of diabetes, DIABETES NEW WORLD, 20, 82
  59. Zhang, 2017, Efficacy of sulfonylureas combined with berberine metformin in the treatment of diabetes, Guidel. Health Care, 25, 252
  60. Zhang, 2012, Clinical observation of berberine in the treatment of type 2 diabetes, J. HEZE Med. Coll., 24, 27
  61. Zhang, 2016, Geniposide acutely stimulates insulin secretion in pancreatic β-cells by regulating GLP-1 receptor/cAMP signaling and ion channels, Mol. Cell. Endocrinol., 430, 89, 10.1016/j.mce.2016.04.020 · DOI
  62. Zhao, 2021, Berberine is an insulin secretagogue targeting the KCNH6 potassium channel, Nat. Commun., 12, 5616, 10.1038/s41467-021-25952-2 · DOI · Paper page
  63. Zhou, 2020, Research progress on chemical compositions of Coptidis Rhizoma and pharmacological effects of berberine, China J. Chin. Materia Medica, 45, 4561, 10.19540/j.cnki.cjcmm.20200527.202 · doi:10.19540/j.cnki.cjcmm.20200527.202
  64. Zhu, 2009, Effect of berberine combined with metformin in the treatment of type II diabetes mellitus, Chin. J. Misdiagn, 9, 788
  65. Zhu, 2015, Gliclazide combined with berberine in the treatment of type 2 diabetes mellitus, zhejiang J. Integr. traditional Chin. West. Med., 25, 915
  66. Zhu, 2020, Effect of berberine on hypoglycemic effect and gut microbiota in patients with newly diagnosed type 2 diabetes mellitus, J. TONGJI Univ. Sci., 41, 467

Cited by

See all 91

Metadata

Authors
Xie, W., Su, F., Wang, G., Peng, Z., Xu, Y., Zhang, Y., Xu, N., Hou, K., Hu, Z., Chen, Y., & Chen, R.
Venue
Frontiers in Pharmacology
Published
2022-11-16
Volume
13
Pages
1015045-1015045
ISSN
1663-9812 (ISSN-L)
OpenAlex
W4309317312
Cited by
91
References
10
FWCI
4.00
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.3389/fphar.2022.1015045
The paper
Xie, W., Su, F., Wang, G., Peng, Z., Xu, Y., Zhang, Y., Xu, N., Hou, K., Hu, Z., Chen, Y., & Chen, R. (2022). Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.1015045

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.